A New Hope in the Treatment of Intraventricular Haemorrhage in Preterm Infants: Mesenchymal Stem Cells.

Autor: Bozkaya D; Ankara City Hospital Child Health and Diseases, Division of Neonatology, Ankara, Turkey., Ceran B, Ozmen E, Okman E, Dizdar EA, Oguz SS, Bozkaya IO
Jazyk: angličtina
Zdroj: Turkish neurosurgery [Turk Neurosurg] 2022; Vol. 32 (2), pp. 344-346.
DOI: 10.5137/1019-5149.JTN.34850-21.2
Abstrakt: To date, there has been no effective treatment to prevent brain damage in premature infants or to prevent the development of post-hemorrhagic hydrocephalus (PHH) after severe intraventricular hemorrhage (IVH). Therefore, new, safe and effective treatment methods need to be developed to improve the prognosis of IVH, for which morbidity and mortality rates are high. Recent studies have shown that the strong immunomodulatory properties of mesenchymal stem cells (MSCs) have an anti-inflammatory effect after IVH, inhibiting the development of PHH and decreasing apoptosis and gliosis, thus improving the self-renewal ability of neuronal tissues. For this reason, MSCs transplantation after IVH is a promising treatment method. In this article, we present a case of grade- III IVH who recovered after MSCs transplantation.
Databáze: MEDLINE